Insys Therapeutics (INSY) Posts Quarterly Results
Insys Therapeutics (NASDAQ:INSY) released its earnings data on Tuesday. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.28, Stock Ratings Network.com reports. The company had revenue of $55.70 million for the quarter, compared to the consensus estimate of $52.77 million.
Insys Therapeutics (NASDAQ:INSY) opened at 30.42 on Tuesday. Insys Therapeutics has a 1-year low of $12.5333 and a 1-year high of $57.9133. The stock has a 50-day moving average of $28.1 and a 200-day moving average of $34.76. The company has a market cap of $1.041 billion and a price-to-earnings ratio of 20.03.
Insys Therapeutics, Inc, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.